AAMI and the British Standards Institute have jointly published guidance documents on performing risk management for machine learning or artificial intelligence incorporating medical devices.
Read More
The reduction in duration of hospital stays and cost-of-care is driving growth of the home infusion therapy market.
Read More
The FDA has cleared Dexcom’s next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes.
Read More
Infusion Associates, provider of medically prescribed outpatient infusion and injection therapies, opened its first Ohio clinic location.
Read More
HeartBeam submitted a 510(k) application to the U.S. FDA for its HeartBeam AIMI platform technology for use in diagnosing heart attacks.
Read More